The bodies of most animals are populated by highly complex and genetically diverse communities of microorganisms. The majority of these microbes reside within the intestines in largely stable but dynamically interactive climax communities that positively interact with their host. Studies from this laboratory have shown that stressor exposure impacts the stability of the microbiota and leads to bacterial translocation. The biological importance of these alterations, however, is not well understood. To determine whether the microbiome contributes to stressor-induced immunoenhancement, mice were exposed to a social stressor called social disruption (SDR), that increases circulating cytokines and primes the innate immune system for enhanced reactivity. Bacterial populations in the cecum were characterized using bacterial tag-encoded FLX amplicon pyrosequencing. Stressor exposure significantly changed the community structure of the microbiota, particularly when the microbiota were assessed immediately after stressor exposure. Most notably, stressor exposure decreased the relative abundance of bacteria in the genus Bacteroides, while increasing the relative abundance of bacteria in the genus Clostridium. The stressor also increased circulating levels of IL-6 and MCP-1, which were significantly correlated with stressorinduced changes to three bacterial genera (i.e., Coprococcus, Pseudobutyrivibrio, and Dorea). In follow up experiments, mice were treated with an antibiotic cocktail to determine whether reducing the microbiota would abrogate the stressor-induced increases in circulating cytokines. Exposure to SDR failed to increase IL-6 and MCP-1 in the antibiotic treated mice. These data show that exposure to SDR significantly affects bacterial populations in the intestines, and remarkably also suggest that the microbiota are necessary for stressor-induced increases in circulating cytokines.
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Introduction
The external surfaces of the body are colonized by vast arrays of microbes that outnumber cells of the body by a factor of 10 (i.e., 10 14 bacterial cells to 10 13 human cells). This means that 90% of the cells of our body are our commensal microbiome. The majority of these microbes reside in the intestines as part of the intestinal microbiota, with microbiota levels ranging from <10 5 bacteria per gram of digesta in the upper parts of the small intestine, to >10 12 bacteria per gram of digesta in the large intestine (Sekirov et al., 2010) . Many of these bacteria are simple opportunistic colonizers, while the majority are true symbiotic organisms in the sense that they have beneficial interactions with each other and the host. For example, many metabolic activities in the intestines are derived from the microbiota, such as the synthesis of vitamin K and vitamin B complex and the metabolism of carcinogens (O'Hara and Shanahan, 2006) . In addition, studies utilizing germ-free mice have now linked changes in the intestinal microbiota to the development of obesity and diabetes (Backhed et al., 2004; Ley et al., 2005; Turnbaugh et al., 2006) . Perhaps one of the most well studied effects of the microbiota on the host, however, is their impact on the immune system. It has long been recognized that the intestinal microbiota affect the mucosal immune system. This has been well documented in germ-free animals that due to a lack of commensal microbiota have smaller Peyer's patches, fewer intraepithelial lymphocytes, and lower levels of secretory IgA (Macpherson and Uhr, 2004) . Importantly, colonizing the germ-free mice with commensal bacteria normalizes these immune parameters, indicating the importance of intestinal bacteria in shaping the mucosal immune response (Macpherson and Uhr, 2004) . The impact that the microbiota can have on systemic immunity has not been as widely 
